UK-based Precision Ocular, a retinal therapeutics company, has closed its Series A funding at 15.5 million pounds (over $20 million). The firm’s investors include Imperial Innovations, Consort Medical plc, NeoMed, V-Bio Ventures and Hovione Scientia Ltd.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: